Tesla and SpaceX form special committees to review possible merger

The boards of SpaceX and Tesla have each formed special committees composed of independent directors to evaluate a possible merger between the two companies. The announcement, made by Elon Musk during SpaceX's Q3 2026 earnings call, marks the most concrete step yet in a process that investors have been pressing for months.

What was announced

The special committees were created at the request of shareholders, according to Musk. Each board assembled its own group, made up exclusively of independent directors — people without an operating role at either company. The goal is to assess whether a combination would make financial and strategic sense for shareholders other than Musk himself.

Musk, who is the largest individual shareholder of both companies and CEO of each, said he would explicitly stay out of the committees' deliberations. "Because I'm a conflicted party, I can't actually be in the discussions of the special committees," he explained, describing the process as "this sort of odd kabuki dance where two groups of people are talking, and I can't be in the conversation."

This recusal is not mere formality. In corporate law, when a controlling shareholder or executive has a dual interest in a deal between companies they control, so-called special purpose committees (SPAC committees) are the standard mechanism to protect minority shareholders. They exist precisely to create a firewall between the interested party and the negotiation.

SpaceX's third-quarter results

The committee announcement came on the same day SpaceX published its Q3 2026 results — and they contained another milestone: the company's first-ever profitable quarter since its IPO. According to SpaceX itself, the result reflects the maturation of three business lines that had been growing in revenue but had not yet generated consistent profit: orbital launches, Starlink connectivity, and AI infrastructure.

The company also disclosed an annualized revenue run rate of up to $31 billion — a figure that places SpaceX among the largest private companies in the world in terms of annual cash flow. The composition of this revenue has shifted significantly: while launch contracts still contribute, Starlink connectivity and AI-adjacent infrastructure work are now taking center stage as the primary revenue drivers.

Investor's Business Daily described the result as "the market's primary takeaway" from SpaceX's quarterly report, alongside the merger narrative itself. The combination of profitability and the merger proposal puts SpaceX in a position without precedent: a company operating in both space and artificial intelligence, now profitable.

The logic of the merger

Musk was emphatic about seeing merit in the combination. "I do think there's a lot of merit to combining the companies as we are pretty much in the superintelligence singularity," he said during the call. He specifically cited areas of collaboration already underway: AI software development, robotics, SpaceX's orbital AI data center project Starmind, and Terafab, the joint semiconductor manufacturing project between Tesla and SpaceX.

The two companies already collaborate on at least three technical fronts. In September, Musk asked chip engineers from both companies to work together on shared projects. Terafab, announced as a semiconductor manufacturing partnership, is designed to produce AI and robotics dedicated chips at scale. And the second-generation Roadster, revealed on October 15 in Waco, Texas, uses cold-gas thrusters developed by SpaceX — the car accelerated from 0 to 60 mph in approximately 0.81 seconds, according to Aviation Week, and can "fly" using the thrusters to change direction.

But technical collaboration is not corporate merger. The question the committees must answer is much more complex: who acquires whom? What would be the exchange rate between Tesla shares (public, on Nasdaq) and SpaceX units (internally priced, but without a public market)? How do you value a $2 trillion company against a $1.5 trillion company in a single deal?

Governance obstacles

Musk highlighted a specific obstacle that often goes unnoticed: the SpaceX IPO consolidated his control with more than 50% of voting power at SpaceX, which would make it easier to garner shareholder support from SpaceX shareholders for any merger. At Tesla, however, the situation is dramatically different — it would require 50% of the vote from ALL shareholders, not just those attending the meeting. Musk called this "quite a high hurdle."

Tesla has seven independent board members under Nasdaq listing standards, including chair Robyn Denholm, Ira Ehrenpreis (who also chairs a committee), former CTO JB Straubel, Joe Gebbia, Jack Hartung, James Murdoch, and Kathleen Wilson-Thompson. Neither Musk nor his brother Kimbal Musk are considered independent. SpaceX lists six independent directors, including Ehrenpreis, who chairs SpaceX's compensation and nominating committee.

One relevant detail: Antonio Garcias, founder of Valor Equity Partners (which holds 3.4% of SpaceX), previously sat on Tesla's board. Valor also financed SpaceX's AI hardware purchases through leaseback arrangements — meaning one of SpaceX's primary investors has complex financial relationships with both companies, potentially complicating the governance of the process even further.

What comes next

No timeline has been disclosed for the committees' work. No transaction structure has been proposed. Barclays, in a note to clients the week before the announcement, suggested a deal could be announced before Tesla's annual shareholder meeting on December 3, 2026 — but neither Tesla nor SpaceX has confirmed that date. The second-generation Roadster, with production scheduled for 2028, remains the only concrete product the two companies have built together so far.

The question that remains: when will investors who paid $125,000 for a Roadster in 2017 discover whether they are betting on a car or on one of the largest corporate mergers in history?

Sources: TechCrunch, Tech Insider, MarketScale

✓ Independent sources cross-checked and verified before publishing